Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00327587
Status:
COMPLETED
Last Update Posted:
2011-11-08
First Post:
2006-05-16
Brief Title:
8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan HCTZ and Amlodipine in Patients With Moderate to Severe Hypertension
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
An 8-week Multicenter Study to Evaluate the Efficacy and Safety of the Combination of ValsartanHCTZAmlodipine Compared to ValsartanHCTZ ValsartanAmlodipine and HCTZAmlodipine in Patients With Moderate to Severe Hypertension
Status:
COMPLETED
Status Verified Date:
2011-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine the safety and efficacy of the various combinations of valsartan HCTZ and amlodipine in patients with moderate to severe hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None